0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Duck Virus Enteritis Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-6D12438
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Duck Virus Enteritis Vaccine Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Duck Virus Enteritis Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-6D12438
Report
September 2024
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Duck Virus Enteritis Vaccine - Market Size

The global market for Duck Virus Enteritis Vaccine was estimated to be worth US$ 67 million in 2023 and is forecast to a readjusted size of US$ 97.9 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030

Duck Virus Enteritis Vaccine - Market

Duck Virus Enteritis Vaccine - Market

Vaccine for Duck Virus Enteritis, A duck enteritis virus- vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Duck Virus Enteritis Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Duck Virus Enteritis Vaccine by region & country, by Type, and by Application.
The Duck Virus Enteritis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Duck Virus Enteritis Vaccine.
Market Segmentation

Scope of Duck Virus Enteritis Vaccine - Market Report

Report Metric Details
Report Name Duck Virus Enteritis Vaccine - Market
Forecasted market size in 2030 US$ 97.9 million
CAGR 5.5%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Duck
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Ceva Santé Animale, Chengdu TECBOND Biological, Institute of Animal Health and Veterinary Biologicals, Institute of Veterinary Preventive Medicine, International Duck Research Cooperative, MSD Animal Health (Merck), Ringpu (Tianjin)Bio-Pharmacy, Veterinary Research Institute
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Duck Virus Enteritis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Duck Virus Enteritis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Duck Virus Enteritis Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Duck Virus Enteritis Vaccine - Market size in 2030?

Ans: The Duck Virus Enteritis Vaccine - Market size in 2030 will be US$ 97.9 million.

Who are the main players in the Duck Virus Enteritis Vaccine - Market report?

Ans: The main players in the Duck Virus Enteritis Vaccine - Market are Ceva Santé Animale, Chengdu TECBOND Biological, Institute of Animal Health and Veterinary Biologicals, Institute of Veterinary Preventive Medicine, International Duck Research Cooperative, MSD Animal Health (Merck), Ringpu (Tianjin)Bio-Pharmacy, Veterinary Research Institute

What are the Application segmentation covered in the Duck Virus Enteritis Vaccine - Market report?

Ans: The Applications covered in the Duck Virus Enteritis Vaccine - Market report are Duck, Others

What are the Type segmentation covered in the Duck Virus Enteritis Vaccine - Market report?

Ans: The Types covered in the Duck Virus Enteritis Vaccine - Market report are Live Vaccines, Killed Vaccines

Recommended Reports

Animal Vaccines

Human Infectious Vaccines

Diagnostic Solutions

1 Market Overview
1.1 Duck Virus Enteritis Vaccine Product Introduction
1.2 Global Duck Virus Enteritis Vaccine Market Size Forecast
1.2.1 Global Duck Virus Enteritis Vaccine Sales Value (2019-2030)
1.2.2 Global Duck Virus Enteritis Vaccine Sales Volume (2019-2030)
1.2.3 Global Duck Virus Enteritis Vaccine Sales Price (2019-2030)
1.3 Duck Virus Enteritis Vaccine Market Trends & Drivers
1.3.1 Duck Virus Enteritis Vaccine Industry Trends
1.3.2 Duck Virus Enteritis Vaccine Market Drivers & Opportunity
1.3.3 Duck Virus Enteritis Vaccine Market Challenges
1.3.4 Duck Virus Enteritis Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Duck Virus Enteritis Vaccine Players Revenue Ranking (2023)
2.2 Global Duck Virus Enteritis Vaccine Revenue by Company (2019-2024)
2.3 Global Duck Virus Enteritis Vaccine Players Sales Volume Ranking (2023)
2.4 Global Duck Virus Enteritis Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Duck Virus Enteritis Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Duck Virus Enteritis Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Duck Virus Enteritis Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Duck Virus Enteritis Vaccine
2.9 Duck Virus Enteritis Vaccine Market Competitive Analysis
2.9.1 Duck Virus Enteritis Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Duck Virus Enteritis Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Duck Virus Enteritis Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Live Vaccines
3.1.2 Killed Vaccines
3.2 Global Duck Virus Enteritis Vaccine Sales Value by Type
3.2.1 Global Duck Virus Enteritis Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Duck Virus Enteritis Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Duck Virus Enteritis Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Duck Virus Enteritis Vaccine Sales Volume by Type
3.3.1 Global Duck Virus Enteritis Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Duck Virus Enteritis Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Duck Virus Enteritis Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Duck Virus Enteritis Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Duck
4.1.2 Others
4.2 Global Duck Virus Enteritis Vaccine Sales Value by Application
4.2.1 Global Duck Virus Enteritis Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Duck Virus Enteritis Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Duck Virus Enteritis Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Duck Virus Enteritis Vaccine Sales Volume by Application
4.3.1 Global Duck Virus Enteritis Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Duck Virus Enteritis Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Duck Virus Enteritis Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Duck Virus Enteritis Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Duck Virus Enteritis Vaccine Sales Value by Region
5.1.1 Global Duck Virus Enteritis Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Duck Virus Enteritis Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Duck Virus Enteritis Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Duck Virus Enteritis Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Duck Virus Enteritis Vaccine Sales Volume by Region
5.2.1 Global Duck Virus Enteritis Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Duck Virus Enteritis Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Duck Virus Enteritis Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Duck Virus Enteritis Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Duck Virus Enteritis Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Duck Virus Enteritis Vaccine Sales Value, 2019-2030
5.4.2 North America Duck Virus Enteritis Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Duck Virus Enteritis Vaccine Sales Value, 2019-2030
5.5.2 Europe Duck Virus Enteritis Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Duck Virus Enteritis Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Duck Virus Enteritis Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Duck Virus Enteritis Vaccine Sales Value, 2019-2030
5.7.2 South America Duck Virus Enteritis Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Duck Virus Enteritis Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Duck Virus Enteritis Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Duck Virus Enteritis Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Duck Virus Enteritis Vaccine Sales Value
6.2.1 Key Countries/Regions Duck Virus Enteritis Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Duck Virus Enteritis Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Duck Virus Enteritis Vaccine Sales Value, 2019-2030
6.3.2 United States Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Duck Virus Enteritis Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Duck Virus Enteritis Vaccine Sales Value, 2019-2030
6.4.2 Europe Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Duck Virus Enteritis Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Duck Virus Enteritis Vaccine Sales Value, 2019-2030
6.5.2 China Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Duck Virus Enteritis Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Duck Virus Enteritis Vaccine Sales Value, 2019-2030
6.6.2 Japan Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Duck Virus Enteritis Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Duck Virus Enteritis Vaccine Sales Value, 2019-2030
6.7.2 South Korea Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Duck Virus Enteritis Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Duck Virus Enteritis Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Duck Virus Enteritis Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Duck Virus Enteritis Vaccine Sales Value, 2019-2030
6.9.2 India Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Duck Virus Enteritis Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Ceva Santé Animale
7.1.1 Ceva Santé Animale Company Information
7.1.2 Ceva Santé Animale Introduction and Business Overview
7.1.3 Ceva Santé Animale Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Ceva Santé Animale Duck Virus Enteritis Vaccine Product Offerings
7.1.5 Ceva Santé Animale Recent Development
7.2 Chengdu TECBOND Biological
7.2.1 Chengdu TECBOND Biological Company Information
7.2.2 Chengdu TECBOND Biological Introduction and Business Overview
7.2.3 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product Offerings
7.2.5 Chengdu TECBOND Biological Recent Development
7.3 Institute of Animal Health and Veterinary Biologicals
7.3.1 Institute of Animal Health and Veterinary Biologicals Company Information
7.3.2 Institute of Animal Health and Veterinary Biologicals Introduction and Business Overview
7.3.3 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product Offerings
7.3.5 Institute of Animal Health and Veterinary Biologicals Recent Development
7.4 Institute of Veterinary Preventive Medicine
7.4.1 Institute of Veterinary Preventive Medicine Company Information
7.4.2 Institute of Veterinary Preventive Medicine Introduction and Business Overview
7.4.3 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product Offerings
7.4.5 Institute of Veterinary Preventive Medicine Recent Development
7.5 International Duck Research Cooperative
7.5.1 International Duck Research Cooperative Company Information
7.5.2 International Duck Research Cooperative Introduction and Business Overview
7.5.3 International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 International Duck Research Cooperative Duck Virus Enteritis Vaccine Product Offerings
7.5.5 International Duck Research Cooperative Recent Development
7.6 MSD Animal Health (Merck)
7.6.1 MSD Animal Health (Merck) Company Information
7.6.2 MSD Animal Health (Merck) Introduction and Business Overview
7.6.3 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product Offerings
7.6.5 MSD Animal Health (Merck) Recent Development
7.7 Ringpu (Tianjin)Bio-Pharmacy
7.7.1 Ringpu (Tianjin)Bio-Pharmacy Company Information
7.7.2 Ringpu (Tianjin)Bio-Pharmacy Introduction and Business Overview
7.7.3 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product Offerings
7.7.5 Ringpu (Tianjin)Bio-Pharmacy Recent Development
7.8 Veterinary Research Institute
7.8.1 Veterinary Research Institute Company Information
7.8.2 Veterinary Research Institute Introduction and Business Overview
7.8.3 Veterinary Research Institute Duck Virus Enteritis Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Veterinary Research Institute Duck Virus Enteritis Vaccine Product Offerings
7.8.5 Veterinary Research Institute Recent Development
8 Industry Chain Analysis
8.1 Duck Virus Enteritis Vaccine Industrial Chain
8.2 Duck Virus Enteritis Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Duck Virus Enteritis Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Duck Virus Enteritis Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Duck Virus Enteritis Vaccine Market Trends
    Table 2. Duck Virus Enteritis Vaccine Market Drivers & Opportunity
    Table 3. Duck Virus Enteritis Vaccine Market Challenges
    Table 4. Duck Virus Enteritis Vaccine Market Restraints
    Table 5. Global Duck Virus Enteritis Vaccine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Duck Virus Enteritis Vaccine Revenue Market Share by Company (2019-2024)
    Table 7. Global Duck Virus Enteritis Vaccine Sales Volume by Company (2019-2024) & (M Units)
    Table 8. Global Duck Virus Enteritis Vaccine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Duck Virus Enteritis Vaccine Price by Company (2019-2024) & (USD/K Unit)
    Table 10. Key Manufacturers Duck Virus Enteritis Vaccine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Duck Virus Enteritis Vaccine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Duck Virus Enteritis Vaccine
    Table 13. Global Duck Virus Enteritis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Duck Virus Enteritis Vaccine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Duck Virus Enteritis Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Duck Virus Enteritis Vaccine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Duck Virus Enteritis Vaccine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Duck Virus Enteritis Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Duck Virus Enteritis Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Duck Virus Enteritis Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (M Units)
    Table 22. Global Duck Virus Enteritis Vaccine Sales Volume by Type (2019-2024) & (M Units)
    Table 23. Global Duck Virus Enteritis Vaccine Sales Volume by Type (2025-2030) & (M Units)
    Table 24. Global Duck Virus Enteritis Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Duck Virus Enteritis Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Duck Virus Enteritis Vaccine Price by Type (2019-2024) & (USD/K Unit)
    Table 27. Global Duck Virus Enteritis Vaccine Price by Type (2025-2030) & (USD/K Unit)
    Table 28. Global Duck Virus Enteritis Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Duck Virus Enteritis Vaccine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Duck Virus Enteritis Vaccine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Duck Virus Enteritis Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Duck Virus Enteritis Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Duck Virus Enteritis Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (M Units)
    Table 34. Global Duck Virus Enteritis Vaccine Sales Volume by Application (2019-2024) & (M Units)
    Table 35. Global Duck Virus Enteritis Vaccine Sales Volume by Application (2025-2030) & (M Units)
    Table 36. Global Duck Virus Enteritis Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Duck Virus Enteritis Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Duck Virus Enteritis Vaccine Price by Application (2019-2024) & (USD/K Unit)
    Table 39. Global Duck Virus Enteritis Vaccine Price by Application (2025-2030) & (USD/K Unit)
    Table 40. Global Duck Virus Enteritis Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Duck Virus Enteritis Vaccine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Duck Virus Enteritis Vaccine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Duck Virus Enteritis Vaccine Sales Value by Region (2019-2024) & (%)
    Table 44. Global Duck Virus Enteritis Vaccine Sales Value by Region (2025-2030) & (%)
    Table 45. Global Duck Virus Enteritis Vaccine Sales Volume by Region (M Units): 2019 VS 2023 VS 2030
    Table 46. Global Duck Virus Enteritis Vaccine Sales Volume by Region (2019-2024) & (M Units)
    Table 47. Global Duck Virus Enteritis Vaccine Sales Volume by Region (2025-2030) & (M Units)
    Table 48. Global Duck Virus Enteritis Vaccine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Duck Virus Enteritis Vaccine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Duck Virus Enteritis Vaccine Average Price by Region (2019-2024) & (USD/K Unit)
    Table 51. Global Duck Virus Enteritis Vaccine Average Price by Region (2025-2030) & (USD/K Unit)
    Table 52. Key Countries/Regions Duck Virus Enteritis Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Duck Virus Enteritis Vaccine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Duck Virus Enteritis Vaccine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Duck Virus Enteritis Vaccine Sales Volume, (2019-2024) & (M Units)
    Table 56. Key Countries/Regions Duck Virus Enteritis Vaccine Sales Volume, (2025-2030) & (M Units)
    Table 57. Ceva Santé Animale Company Information
    Table 58. Ceva Santé Animale Introduction and Business Overview
    Table 59. Ceva Santé Animale Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 60. Ceva Santé Animale Duck Virus Enteritis Vaccine Product Offerings
    Table 61. Ceva Santé Animale Recent Development
    Table 62. Chengdu TECBOND Biological Company Information
    Table 63. Chengdu TECBOND Biological Introduction and Business Overview
    Table 64. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 65. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product Offerings
    Table 66. Chengdu TECBOND Biological Recent Development
    Table 67. Institute of Animal Health and Veterinary Biologicals Company Information
    Table 68. Institute of Animal Health and Veterinary Biologicals Introduction and Business Overview
    Table 69. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 70. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product Offerings
    Table 71. Institute of Animal Health and Veterinary Biologicals Recent Development
    Table 72. Institute of Veterinary Preventive Medicine Company Information
    Table 73. Institute of Veterinary Preventive Medicine Introduction and Business Overview
    Table 74. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 75. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product Offerings
    Table 76. Institute of Veterinary Preventive Medicine Recent Development
    Table 77. International Duck Research Cooperative Company Information
    Table 78. International Duck Research Cooperative Introduction and Business Overview
    Table 79. International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 80. International Duck Research Cooperative Duck Virus Enteritis Vaccine Product Offerings
    Table 81. International Duck Research Cooperative Recent Development
    Table 82. MSD Animal Health (Merck) Company Information
    Table 83. MSD Animal Health (Merck) Introduction and Business Overview
    Table 84. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 85. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product Offerings
    Table 86. MSD Animal Health (Merck) Recent Development
    Table 87. Ringpu (Tianjin)Bio-Pharmacy Company Information
    Table 88. Ringpu (Tianjin)Bio-Pharmacy Introduction and Business Overview
    Table 89. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 90. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product Offerings
    Table 91. Ringpu (Tianjin)Bio-Pharmacy Recent Development
    Table 92. Veterinary Research Institute Company Information
    Table 93. Veterinary Research Institute Introduction and Business Overview
    Table 94. Veterinary Research Institute Duck Virus Enteritis Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 95. Veterinary Research Institute Duck Virus Enteritis Vaccine Product Offerings
    Table 96. Veterinary Research Institute Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Duck Virus Enteritis Vaccine Downstream Customers
    Table 100. Duck Virus Enteritis Vaccine Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Duck Virus Enteritis Vaccine Product Picture
    Figure 2. Global Duck Virus Enteritis Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Duck Virus Enteritis Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Duck Virus Enteritis Vaccine Sales Volume (2019-2030) & (M Units)
    Figure 5. Global Duck Virus Enteritis Vaccine Sales Price (2019-2030) & (USD/K Unit)
    Figure 6. Duck Virus Enteritis Vaccine Report Years Considered
    Figure 7. Global Duck Virus Enteritis Vaccine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Duck Virus Enteritis Vaccine Players Sales Volume Ranking (2023) & (M Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Duck Virus Enteritis Vaccine Revenue in 2023
    Figure 10. Duck Virus Enteritis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Live Vaccines Picture
    Figure 12. Killed Vaccines Picture
    Figure 13. Global Duck Virus Enteritis Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Duck Virus Enteritis Vaccine Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Duck Virus Enteritis Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (M Units)
    Figure 16. Global Duck Virus Enteritis Vaccine Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Duck Virus Enteritis Vaccine Price by Type (2019-2030) & (USD/K Unit)
    Figure 18. Product Picture of Duck
    Figure 19. Product Picture of Others
    Figure 20. Global Duck Virus Enteritis Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Duck Virus Enteritis Vaccine Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Duck Virus Enteritis Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (M Units)
    Figure 23. Global Duck Virus Enteritis Vaccine Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Duck Virus Enteritis Vaccine Price by Application (2019-2030) & (USD/K Unit)
    Figure 25. North America Duck Virus Enteritis Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Duck Virus Enteritis Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Duck Virus Enteritis Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Duck Virus Enteritis Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Duck Virus Enteritis Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Duck Virus Enteritis Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Duck Virus Enteritis Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Duck Virus Enteritis Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Duck Virus Enteritis Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Duck Virus Enteritis Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Duck Virus Enteritis Vaccine Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Duck Virus Enteritis Vaccine Sales Volume (%), (2019-2030)
    Figure 37. United States Duck Virus Enteritis Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Duck Virus Enteritis Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Duck Virus Enteritis Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Duck Virus Enteritis Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Duck Virus Enteritis Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Duck Virus Enteritis Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Duck Virus Enteritis Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Duck Virus Enteritis Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Duck Virus Enteritis Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Duck Virus Enteritis Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Duck Virus Enteritis Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Duck Virus Enteritis Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Duck Virus Enteritis Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Duck Virus Enteritis Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Duck Virus Enteritis Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 58. Duck Virus Enteritis Vaccine Industrial Chain
    Figure 59. Duck Virus Enteritis Vaccine Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS